Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 19, 2011

IN RE: K-V Pharmaceutical Company Securities Litigation

Track this case

Case Number:

4:11-cv-01816

Court:

Missouri Eastern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Audrey G. Fleissig

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 06, 2014

    K-V Investors Can't Save Suit Over Pregnancy Drug

    A Missouri federal judge on Friday dismissed K-V Pharmaceutical Co. investors' consolidated securities fraud class action accusing the company of lying about prospects for pregnancy drug Makena, artificially inflating the stock price that later plummeted, and refused their proposals to amend it.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login